122 related articles for article (PubMed ID: 5131086)
21. Factors affecting the metabolic production of methylguanidine.
Gonella M; Barsotti G; Lupetti S; Giovannetti S
Clin Sci Mol Med; 1975 May; 48(5):341-7. PubMed ID: 1126127
[TBL] [Abstract][Full Text] [Related]
22. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
[TBL] [Abstract][Full Text] [Related]
23. [Dialysis of methylguanidine and hypothesis on the middle molecules].
Barsotti G; Giovannetti S
Ateneo Parmense Acta Biomed; 1975; 46(5):317-30. PubMed ID: 1232993
[TBL] [Abstract][Full Text] [Related]
24. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
[TBL] [Abstract][Full Text] [Related]
25. A new automated analytical method for gaunidino compounds and their cerebrospinal fluid levels in uremia.
Yamamoto Y; Saito A; Manji T; Nishi H; Ito K; Maeda K; Ohta K; Kobayashi K
Trans Am Soc Artif Intern Organs; 1978; 24():61-8. PubMed ID: 716068
[No Abstract] [Full Text] [Related]
26. Concentration of guanidines in normal human plasma.
Lazdins I; Dawborn JK
Clin Exp Pharmacol Physiol; 1978; 5(1):75-80. PubMed ID: 639360
[TBL] [Abstract][Full Text] [Related]
27. Dialysis of methylguanidine.
Giovannetti S; Barsotti G
Kidney Int; 1974 Sep; 6(3):177-83. PubMed ID: 4425483
[No Abstract] [Full Text] [Related]
28. Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism.
Balestri PL; Rindi P; Biagini M; Giovannetti S
Clin Sci; 1972 Apr; 42(4):395-404. PubMed ID: 5020280
[No Abstract] [Full Text] [Related]
29. Inhibitory effects of plasma from uraemic patients on human mononuclear phagocytes cultured in vitro.
Jorstad S; Viken KE
Acta Pathol Microbiol Scand C; 1977 Jun; 85(3):169-77. PubMed ID: 327752
[TBL] [Abstract][Full Text] [Related]
30. Semiautomated method for measurement of guanidinosuccinic acid in serum.
Kamoun PP; Pleau JM; Man NK
Clin Chem; 1972 Apr; 18(4):355-7. PubMed ID: 5012258
[No Abstract] [Full Text] [Related]
31. Utilization of adsorbing materials for uremic blood purification.
Denti E
Biomater Med Devices Artif Organs; 1974; 2(3):295-300. PubMed ID: 4458819
[No Abstract] [Full Text] [Related]
32. Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.
Sasagawa I; Nakada T; Kubota Y; Sawamura T; Suzuki H; Hashimoto T
Int Urol Nephrol; 1994; 26(6):701-5. PubMed ID: 7759207
[TBL] [Abstract][Full Text] [Related]
33. Ion exchange chromatographic, gel filtration and isotachophoretic analysis of normal and uraemic sera.
Menyhárt J; Gróf J
Acta Chir Acad Sci Hung; 1981; 22(1-2):47-60. PubMed ID: 7345835
[No Abstract] [Full Text] [Related]
34. Chromatographic evaluation of perfusion on charcoal in uraemia.
Laganà A; Liberti A; Politi L; Scandurra R; Cerulli N
J Chromatogr; 1985 Dec; 345(2):251-8. PubMed ID: 4086596
[TBL] [Abstract][Full Text] [Related]
35. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
[No Abstract] [Full Text] [Related]
36. [Studies on the significance of middle molecular retention products as uremia toxins].
Goubeaud G; Leber HW; Schott HH
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827
[No Abstract] [Full Text] [Related]
37. Cation-exchange chromatography of guanidine derivatives in plasma of patients with chronic renal failure.
Perez G; Rey A; Micklus M; Stein I
Clin Chem; 1976 Feb; 22(2):240-2. PubMed ID: 1248127
[TBL] [Abstract][Full Text] [Related]
38. Determination of guanidino compounds by anion-exchange chromatography and amperometric detection.
Ding WD; Veening H; Van Effen RM
J Chromatogr; 1990 Apr; 526(2):355-66. PubMed ID: 2361978
[TBL] [Abstract][Full Text] [Related]
39. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
[TBL] [Abstract][Full Text] [Related]
40. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
